Literature DB >> 7640159

The alpha spending function approach to interim data analyses.

D L DeMets1, G Lan.   

Abstract

Mesh：

Year:  1995        PMID： 7640159     DOI： 10.1007/978-1-4615-2009-2_1

Source DB:  PubMed          Journal:  Cancer Treat Res        ISSN： 0927-3042


× No keyword cloud information.
  9 in total

1.  Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopy.

Authors:  Robert E Schoen; Paul F Pinsky; Joel L Weissfeld; Lance A Yokochi; Timothy Church; Adeyinka O Laiyemo; Robert Bresalier; Gerald L Andriole; Saundra S Buys; E David Crawford; Mona N Fouad; Claudine Isaacs; Christine C Johnson; Douglas J Reding; Barbara O'Brien; Danielle M Carrick; Patrick Wright; Thomas L Riley; Mark P Purdue; Grant Izmirlian; Barnett S Kramer; Anthony B Miller; John K Gohagan; Philip C Prorok; Christine D Berg
Journal:  N Engl J Med       Date:  2012-05-21       Impact factor: 91.245

2.  Phase III trial of weekly methotrexate or pulsed dactinomycin for low-risk gestational trophoblastic neoplasia: a gynecologic oncology group study.

Authors:  Raymond J Osborne; Virginia Filiaci; Julian C Schink; Robert S Mannel; Angeles Alvarez Secord; Joseph L Kelley; Diane Provencher; David Scott Miller; Allan L Covens; Janice M Lage
Journal:  J Clin Oncol       Date:  2011-01-24       Impact factor: 44.544

3.  Laparoscopic versus open resections in the posterosuperior liver segments within an enhanced recovery programme (ORANGE Segments): study protocol for a multicentre randomised controlled trial.

Authors:  Christoph Kuemmerli; Robert S Fichtinger; Alma Moekotte; Luca A Aldrighetti; Somaiah Aroori; Marc G H Besselink; Mathieu D'Hondt; Rafael Díaz-Nieto; Bjørn Edwin; Mikhail Efanov; Giuseppe M Ettorre; Krishna V Menon; Aali J Sheen; Zahir Soonawalla; Robert Sutcliffe; Roberto I Troisi; Steven A White; Lloyd Brandts; Gerard J P van Breukelen; Jasper Sijberden; Siân A Pugh; Zina Eminton; John N Primrose; Ronald van Dam; Mohammed Abu Hilal
Journal:  Trials       Date:  2022-03-09       Impact factor: 2.279

4.  Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma: A Randomized Clinical Trial.

Authors:  Roger Stupp; Sophie Taillibert; Andrew Kanner; William Read; David Steinberg; Benoit Lhermitte; Steven Toms; Ahmed Idbaih; Manmeet S. Ahluwalia; Karen Fink; Francesco Di Meco; Frank Lieberman; Jay-Jiguang Zhu; Giuseppe Stragliotto; David Tran; Steven Brem; Andreas Hottinger; Eilon D. Kirson; Gitit Lavy-Shahaf; Uri Weinberg; Chae-Yong Kim; Sun-Ha Paek; Garth Nicholas; Jordi Bruna; Hal Hirte; Michael Weller; Yoram Palti; Monika E. Hegi; Zvi Ram
Journal:  JAMA       Date:  2017-12-19       Impact factor: 56.272

5.  A Bayesian Sequential Design for Clinical Trials with Time-to-Event Outcomes.

Authors:  Lin Zhu; Qingzhao Yu; Donald E Mercante
Journal:  Stat Biopharm Res       Date:  2019-07-22       Impact factor: 1.452

6.  Secondary Surgical Cytoreduction for Recurrent Ovarian Cancer.

Authors:  Robert L Coleman; Nick M Spirtos; Danielle Enserro; Thomas J Herzog; Paul Sabbatini; Deborah K Armstrong; Jae-Weon Kim; Sang-Yoon Park; Byoung-Gie Kim; Joo-Hyun Nam; Keiichi Fujiwara; Joan L Walker; Ann C Casey; Angeles Alvarez Secord; Steve Rubin; John K Chan; Paul DiSilvestro; Susan A Davidson; David E Cohn; Krishnansu S Tewari; Karen Basen-Engquist; Helen Q Huang; Mark F Brady; Robert S Mannel
Journal:  N Engl J Med       Date:  2019-11-14       Impact factor: 91.245

7.  Final Report of the Intergroup Randomized Study of Combined Androgen-Deprivation Therapy Plus Radiotherapy Versus Androgen-Deprivation Therapy Alone in Locally Advanced Prostate Cancer.

Authors:  Malcolm D Mason; Wendy R Parulekar; Matthew R Sydes; Michael Brundage; Peter Kirkbride; Mary Gospodarowicz; Richard Cowan; Edmund C Kostashuk; John Anderson; Gregory Swanson; Mahesh K B Parmar; Charles Hayter; Gordana Jovic; Andrea Hiltz; John Hetherington; Jinka Sathya; James B P Barber; Michael McKenzie; Salah El-Sharkawi; Luis Souhami; P D John Hardman; Bingshu E Chen; Padraig Warde
Journal:  J Clin Oncol       Date:  2015-02-17       Impact factor: 44.544

8.  Creating a Framework for Conducting Randomized Clinical Trials during Disease Outbreaks.

Authors:  Natalie E Dean; Pierre-Stéphane Gsell; Ron Brookmeyer; Forrest W Crawford; Christl A Donnelly; Susan S Ellenberg; Thomas R Fleming; M Elizabeth Halloran; Peter Horby; Thomas Jaki; Philip R Krause; Ira M Longini; Sabue Mulangu; Jean-Jacques Muyembe-Tamfum; Martha C Nason; Peter G Smith; Rui Wang; Ana M Henao-Restrepo; Victor De Gruttola
Journal:  N Engl J Med       Date:  2020-04-02       Impact factor: 176.079

9.  Analysis of phase II methodologies for single-arm clinical trials with multiple endpoints in rare cancers: An example in Ewing's sarcoma.

Authors:  P Dutton; S B Love; L Billingham; A B Hassan
Journal:  Stat Methods Med Res       Date:  2016-09-01       Impact factor: 3.021
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.